Prokocimer Philippe 4
4 · Trius Therapeutics Inc · Filed Jan 18, 2012
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-01-13$0.52/sh+4,000$2,080→ 85,070 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2012-01-13−4,000→ 6,244 totalExercise: $0.52Exp: 2018-01-09→ Common Stock (4,000 underlying)
Holdings
- 17,894
Common Stock
Footnotes (2)
- [F1]Includes 693 shares acquired under the TSRX Employee Stock Purchase Plan (the "ESPP") on November 18, 2011.
- [F2]25% of the shares subject to the 14,244 share option grant vested on 1/1/09, with the remainder vesting monthly thereafter until fully vested on 1/1/12.